Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan
Canada

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

pharmacompass-1-m-2026-01-12

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

Contact Supplier

Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

Contact Supplier

pharmacompass-2-2026-02-09

Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

36 API Suppliers, 18 USDMF, 3 CEP/COS, 5 JDMF, 11 EU WC, 4 KDMF, 9 NDC API, 19 Listed Suppliers, $ API Reference Price

36 API Suppliers
18 USDMF
3 CEP/COS
5 JDMF
11 EU WC
4 KDMF
9 NDC API
19 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

15 Drugs in Development

15 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

304 FDF Dossiers, 52 FDA Orange Book, 211 Europe, 19 Canada, 3 Australia, 3 South Africa, 16 Listed Dossiers

304 FDF Dossiers
52 FDA Orange Book
211 Europe
19 Canada
3 Australia
3 South Africa
16 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 5 Evonik, 3 Rochem International Inc, 19 SPI Pharma, 4 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 2 Kirsch Pharma, 1 Panvo Organics, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 1 Avesta Pharma, 22 BASF, 3 Clariant, 13 Corel Pharma Chem, 6 DFE Pharma, 1 Doshion Polyscience, 1 Esteem Industries, 1 Finar, 13 Gangwal Chemicals, 2 Gloria Interchem, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 26 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 19 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

63 Fillers, Diluents & Binders, 50 Coating Systems & Additives, 41 Direct Compression, 39 Disintegrants & Superdisintegrants, 31 Taste Masking, 30 Granulation, 26 Thickeners and Stabilizers, 24 Controlled & Modified Release, 24 Lubricants & Glidants, 22 Solubilizers, 22 Chewable & Orodispersible Aids, 19 Topical, 19 Film Formers & Plasticizers, 16 Parenteral, 13 Co-Processed Excipients, 9 Empty Capsules, 8 API Stability Enhancers, 8 Emulsifying Agents, 6 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 4 Rheology Modifiers, 2 Coloring Agents

63 Fillers, Diluents & Binders
50 Coating Systems & Additives
41 Direct Compression
39 Disintegrants & Superdisintegrants
31 Taste Masking
30 Granulation
26 Thickeners and Stabilizers
24 Controlled & Modified Release
24 Lubricants & Glidants
22 Solubilizers
22 Chewable & Orodispersible Aids
19 Topical
19 Film Formers & Plasticizers
16 Parenteral
13 Co-Processed Excipients
9 Empty Capsules
8 API Stability Enhancers
8 Emulsifying Agents
6 Surfactant & Foaming Agents
4 Vegetarian Capsules
4 Rheology Modifiers
2 Coloring Agents

DIGITAL CONTENT

27 News #PharmaBuzz

27 News #PharmaBuzz

GLOBAL SALES INFORMATION

13 US Medicaid Prescriptions, 30 Regulatory FDF Prices

13 US Medicaid Prescriptions
30 Regulatory FDF Prices

MARKET PLACE

14 APIs

14 APIs

PATENTS & EXCLUSIVITIES

10 Health Canada Patents

10 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 Others

3 Others

$ API Ref.Price (USD/KG) : 9,428 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

19 All

01 1AURO PHARMA INC

02 1BIOMED PHARMA

03 1JAMP PHARMA CORPORATION

04 1MARCAN PHARMACEUTICALS INC

05 1MINT PHARMACEUTICALS INC

06 1NATCO PHARMA (CANADA) INC

07 1NORA PHARMA INC

08 1Natco Pharma Limited

09 2Pharmascience Inc.

10 2SANDOZ CANADA INCORPORATED

11 1SANIS HEALTH INC

12 2TEVA CANADA LIMITED

13 4XEDITON PHARMACEUTICALS INC

filter Active Ingredients Reset all filters

19 All

01 16ZOLMITRIPTAN

02 3Zolmitriptan

filter Dosage Form Reset all filters

19 All

01 1FC TABLET (ORALLY DISINTEGRATING)

02 2SPRAY

03 12TABLET

04 3TABLET (ORALLY DISINTEGRATING)

05 1Tablet

filter Brand Name Reset all filters

19 All

01 1AURO-ZOLMITRIPTAN

02 1BIO-ZOLMITRIPTAN

03 1JAMP-ZOLMITRIPTAN

04 1MAR-ZOLMITRIPTAN

05 1MINT-ZOLMITRIPTAN

06 2NAT-ZOLMITRIPTAN

07 1NRA-ZOLMITRIPTAN

08 1PMS-ZOLMITRIPTAN

09 1PMS-ZOLMITRIPTAN ODT

10 1SANDOZ ZOLMITRIPTAN

11 1SANDOZ ZOLMITRIPTAN ODT

12 1TEVA-ZOLMITRIPTAN

13 1TEVA-ZOLMITRIPTAN OD

14 1ZOLMITRIPTAN

15 1ZOMIG

16 2ZOMIG NASAL SPRAY

17 1ZOMIG RAPIMELT

List of Suppliers

Product Main Page

01

AURO PHARMA INC

euroPLX 90 Lisbon

Not Confirmed

AURO PHARMA INC

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

ZOLMITRIPTAN

Brand Name : AURO-ZOLMITRIPTAN

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging : Jun-30

Approval Date :

Application Number : 2481030

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

BIOMED PHARMA

euroPLX 90 Lisbon

Not Confirmed

BIOMED PHARMA

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

ZOLMITRIPTAN

Brand Name : BIO-ZOLMITRIPTAN

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging :

Approval Date :

Application Number : 2512831

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

JAMP PHARMA CORPORATION

BIO CEO & Investor

Not Confirmed

JAMP PHARMA CORPORATION

BIO CEO & Investor

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

ZOLMITRIPTAN

Brand Name : JAMP-ZOLMITRIPTAN

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging : 6

Approval Date :

Application Number : 2421623

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

MARCAN PHARMACEUTICALS INC

BIO CEO & Investor

Not Confirmed

MARCAN PHARMACEUTICALS INC

BIO CEO & Investor

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

ZOLMITRIPTAN

Brand Name : MAR-ZOLMITRIPTAN

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging :

Approval Date :

Application Number : 2399458

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

MINT PHARMACEUTICALS INC

euroPLX 90 Lisbon

Not Confirmed

MINT PHARMACEUTICALS INC

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

ZOLMITRIPTAN

Brand Name : MINT-ZOLMITRIPTAN

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging : 6

Approval Date :

Application Number : 2419521

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Natco Pharma Limited

BIO CEO & Investor

Not Confirmed

Natco Pharma Limited

BIO CEO & Investor

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Zolmitriptan

Brand Name : NAT-ZOLMITRIPTAN

Dosage Form : Tablet

Dosage Strength : 2.5MG

Packaging : 6/10/100/1000

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

NATCO PHARMA (CANADA) INC

BIO CEO & Investor

Not Confirmed

NATCO PHARMA (CANADA) INC

BIO CEO & Investor

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

ZOLMITRIPTAN

Brand Name : NAT-ZOLMITRIPTAN

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging : 6/10/100/1000

Approval Date :

Application Number : 2421534

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

NORA PHARMA INC

euroPLX 90 Lisbon

Not Confirmed

NORA PHARMA INC

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

ZOLMITRIPTAN

Brand Name : NRA-ZOLMITRIPTAN

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging :

Approval Date :

Application Number : 2489392

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Pharmascience Inc.

BIO CEO & Investor

Not Confirmed

Pharmascience Inc.

BIO CEO & Investor

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Zolmitriptan

Brand Name : PMS-ZOLMITRIPTAN ODT

Dosage Form : FC TABLET (ORALLY DISINTEGRATING)

Dosage Strength : 2.5MG

Packaging : 42551

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Pharmascience Inc.

BIO CEO & Investor

Not Confirmed

Pharmascience Inc.

BIO CEO & Investor

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Zolmitriptan

Brand Name : PMS-ZOLMITRIPTAN

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging : 42551

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.